About the company
Skalar Pharma is the owner of a large chemical-pharmaceutical plant located in Guayama, Puerto Rico with four state-of-the-art facilities and a supporting campus for producing active pharmaceutical ingredients (“API”s).
November 17, 2021
Corbel Capital Partners announced that it closed a structured investment in support of the restart of Skalar Pharma Holding LLC (“Skalar”).
Skalar is the owner of a state-of-the art active pharmaceutical ingredient (“API”) production campus, based in Guyama, Puerto Rico, which is fully equipped with advanced equipment and infrastructure for production of molecules. Originally constructed by Astra Zeneca in 1992, the production campus plant’s products were historically approved by top US, European, and Asian regulating bodies, with prior owners producing over 30 different complex molecules out of its footprint. Most recently the plant was owned by Eli Lilly producing several APIs as a global supplier, prior to the sale of the plant to Skalar. Corbel made the investment in partnership with Skalar chairman Fernando Londono, a biopharmaceutical industry veteran with a track record of success based in Bogota, Colombia. This is the third investment of Corbel DSOF Capital Management (“DSOF”). DSOF aims to provide creatively-structured capital solutions to meet the needs of various constituencies in special and otherwise-complex situations. Corbel’s differentiated, one-stop capital solution demonstrates Corbel’s ability to creatively structure investments alongside owners in special situations to create attractive risk reward opportunities.
Current Investments
